06833 SINCO PHARMA
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.14X | Oper Margin | 4.1% |
|---|---|---|---|
| LT Debt/Equity | 0.7% | Net Margin | 1.5% |
| Total Debt/Equity | 52.9% | Return on Equity | 6.3% |
| Price/Book | 0.71X | Return on Assets | 2.1% |
| (HKD 0.246) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 44.71 | 46.68 | 77.88 | 165.22 | 140.20 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -4.2 | -40.1 | -52.9 | +17.8 | +447.7 |
| Earnings Per Share (HKD) | 0.022 | 0.023 | 0.038 | 0.095 | 0.083 |
| Earnings Per Share Growth (%) | -4.4 | -40.0 | -59.7 | +14.7 | +449.0 |
| Dividend Per Share (HKD) | 0.002 | 0.004 | 0.010 | No dividend | No dividend |
| P/E* (X) | 11.18 | 10.70 | 6.42 | 2.59 | 2.97 |
| Yield (%) | 0.81 | 1.59 | 3.98 | N/A | N/A |
| Dividend Share (%) | 9.09 | 16.96 | 25.59 | N/A | N/A |
| Book NAV (HKD) | 0.347 | 0.341 | 0.333 | 0.245 | 0.116 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-07 21:40:22
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 1,196 | 1,527 | -21.7 | 1,090 |
| Operating Result | 34.748 | 67.994 | -48.9 | 42.733 |
| Profit Before Taxation | 36.556 | 67.994 | -46.2 | 42.769 |
| Taxation | 12.167 | 44.124 | -72.4 | 23.174 |
| Profit /( Loss) After Taxation | 24.389 | 23.87 | +2.2 | 19.595 |
| Net Profit | 24.389 | 23.87 | +2.2 | 19.595 |
| Earnings Per Share () | 0.0131 | 0.0126 | +4.0 | 0.0104 |
| Announcement Date | 2025-08-27 | 2024-08-28 | NA | 2023-08-30 |
* Annualised
Last Update Time: 2025-09-07 21:40:27
